In response to an upswell of vaccine hesitancy and refusal since 2007, the American Academy of Pediatrics is arming pediatricians with another tool to force…

Pennsylvania's Inovio Pharmaceuticals continues to forge ahead with its Zika work, announcing Monday that its second vaccine trial in humans is underway…

While it wasn’t implicated in the illegal vaccine sales ring that rocked China earlier this year, Beijing-based Sinovac has surely felt the pain. In second-…

As it works to advance an HIV vaccine candidate, the University of Maryland’s Institute of Human Virology this week received a $14.4 million grant for its…

HHS Secretary Sylvia Burwell has signed off on an $81 million fund allocation for federal agencies to continue research, though officials are stressing the…

With the former Novartis flu vaccine unit in hand, CSL has big plans for its newly formed flu vaccines unit Seqirus. But it’ll be a bumpy path toward reaching…

Following the June decision by a CDC committee to recommend against any use of AstraZeneca’s FluMist Quadrivalent for the upcoming flu season, a Canadian study…

Dynavax Technologies has a new FDA Adcomm date for consideration of its hepatitis B vaccine, Heplisav-B, after the agency earlier this year pushed back its…